Skip to the main content.

Cell and Gene Therapy Series. Part 7 - Manufacturing Paradigms part II

Cell and Gene Blog Series: Part 7 - Future ATMP Manufacturing Paradigms

We wrap up this Cell and Gene series with a final blog - 7. Follow the link to continue learning about the future of ATMPs' manufacturing paradigm.

Filling syringes with spray-dried powders - the how, the why and the benefits

Filling syringes with spray-dried powders - the how, the why and the benefits

For many in the industry, it still comes as a surprise: you can fill syringes with spray-dried powders. Ready-to-use, pre-filled syringes...

Read More
What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...

Read More
The Shift to GMP-Compliant Automation in Cell and Gene Therapy Manufacturing

The Shift to GMP-Compliant Automation in Cell and Gene Therapy Manufacturing

Cell and gene therapies (CGTs) offer the potential to cure a wide range of life-limiting diseases. Known as Advanced Therapy Medicinal Products...

Read More